Revance Therapeutics Inc (NASDAQ:RVNC)

26.63
BATS BZX Real-Time Price
As of 12:24pm ET
 +0.94 / +3.66%
Today’s Change
11.27
Today|||52-Week Range
29.51
+63.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
AssetsCash201.7M63.5M282.9M73.3M
 
 
 
 
 
Short Term Investment Cash30.6M-138.0M219.4M-209.5M
 
 
 
 
 
Cash & Short Term Investments252.3M185.5M282.9M175.8M
 
 
 
 
 
 
ReceivablesReceivables158.0K6.0M48.0K27.0M
 
 
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsPrepaid Expenses1.2M978.0K1.8M--
 
 
 
 
Other Current Assets267.0K163.0K444.0K5.1M
 
 
 
 
 
Current Assets254.0M192.7M285.2M207.9M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross31.2M22.7M22.8M28.4M
 
 
 
 
 
Depreciation-11.5M-12.2M-13.5M-14.0M
 
 
 
 
 
Other Assets0.00500.0K658.0K3.2M
 
 
 
 
Total Assets275.8M204.4M295.7M226.3M
 
 
 
 
 
 
LiabilitiesAccounts Payable2.7M3.8M6.8M8.4M
 
 
 
 
 
Short Term Debt3.1M3.5M1.9M0.00
 
 
 
 
Accrued Expenses2.0M7.9M3.7M5.3M
 
 
 
 
 
Other Current Liabilities3.0M8.6M4.7M14.5M
 
 
 
 
 
Other Liabilities12.0M19.6M20.9M32.0M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt5.3M1.9M0.000.00
 
 
 
Other Liabilities1.4M5.8M6.0M6.1M
 
 
 
 
 
Total Liabilities22.6M27.3M26.9M80.7M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity253.3M177.1M268.8M145.6M
 
 
 
 
 
Total Shareholder Equity253.3M177.1M268.8M145.6M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding28.3M28.6M36.5M37.0M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.